CDC HAN Health Advisory| Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir
December 14, 2022 the CDC released a HAN Health Advisory regarding Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir.
Find out more at: https://emergency.cdc.gov/han/2022/han00482.asp
Sign up for Email Updates
How low can you go (in duration of therapy)? Join Nicole Slain and Katie Olney as they compare 5 vs 10 days of antibiotic therapy for pediatric febrile urinary tract infections in our latest SIDP Journal Club series (sidp.org/BCIDP), worth 1.5h of ACPE/BCIDP credit!